You searched for: romiplostim (Engelska - Slovenska)

romiplostim (n = 41)
0, 0175

loss of response to romiplostim
pojav neodzivnosti na romiplostim

total vial content of romiplostim
celokupna vsebina romiplostima v viali

the active substance is romiplostim.
zdravilna učinkovina je romiplostim.

each vial contains 250 µg of romiplostim.
ena viala vsebuje 250 µg romiplostima.

it contains the active substance romiplostim.
vsebuje zdravilno učinkovino romiplostim.

nplate 250 µg powder for injection romiplostim sc
nplate 250 µg prašek za injiciranje romiplostim s. c.

carton containing 1 or 4 vials of romiplostim.
Škatla, ki vsebuje 1 ali 4 viale z romiplostimom.

the carcinogenic potential of romiplostim has not been evaluated.
kancerogenega potenciala romiplostima niso ocenjevali.

in clinical studies, antibodies to romiplostim were examined.
protitelesa, ki so nevtralizirala delovanje romiplostima, so se pojavila pri 1 od 271 itp bolnikov, ki so prejemali romiplostim v kliničnem programu itp.

nplate 250 micrograms powder for solution for injection romiplostim
nplate 250 mikrogramov prašek za raztopino za injiciranje romiplostim

romiplostim has no amino acid sequence homology to endogenous tpo.
aminokislinsko zaporedje romiplostima ni homologno endogenemu tpo.

75 kg patient is initiated at 1 µg/kg of romiplostim.
zdravljenje 75 kg bolnika se začne z 1 µg/kg romiplostima.

it is not known whether romiplostim is present in human milk.
ni znano, ali se romiplostim pojavi v materinem mleku.

romiplostim serum levels appear inversely related to platelet counts.
koncentracija romiplostima v serumu je obratno sorazmerna številu trombocitov.

it is unknown whether romiplostim/metabolites are excreted in human milk.
ni znano, ali se romiplostim/presnovki izločajo v materino mleko.

in early clinical studies, the maximum dose of romiplostim was 30 µg/ kg.
v zgodnjih kliničnih študijah je bil največji odmerek romiplostima 30 µg/ kg.

romiplostim is produced by recombinant dna technology in escherichia coli (e. coli).
romiplostim je pridobljen v escherichia coli (e. coli) s tehnologijo rekombinantne dna.

in all developmental studies neutralising antibodies were formed, which may have inhibited romiplostim effects.
v vseh razvojnih študijah so nastajala nevtralizirajoča protitelesa, ki so morda zavrla učinke romiplostima.

nplate 250 micrograms powder for solution for injection nplate 500 micrograms powder for solution for injection romiplostim
nplate 250 mikrogramov prašek za raztopino za injiciranje nplate 500 mikrogramov prašek za raztopino za injiciranje romiplostim